News Siegfried opens global R&D Center for Drug Substances in Switzerland The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth By IPP Bureau | November 21, 2024 Siegfried, a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in...
Tag: Siegfried
Post
Post
Switzerland: EGS Beteiligungen raises stake in Siegfried with exercise of convertible bond
EGS Beteiligungen, the investment arm of the Ernst Göhner Foundation, has exercised its right to convert Siegfried convertible bonds issued in December 2020 with a coupon of 1.15% and a nominal value of CHF40m (US$47m) into shares of global life sciences company, Siegfried Holding. The Swiss investor receives 48,054 shares, increasing its stake in Siegfried...
Post
Switzerland: EGS Beteiligungen increases stake in Siegfried with exercise of CB
Swiss investor, EGS Beteiligungen, has increased its stake in Swiss CDMO Siegfried from 5% to around 6.2% following the exercise of its right to convert one of Siegfried’s convertible bonds issued in December 2020 with a coupon of 0.65% and a nominal value of CHF40m (US$45m) into shares of Siegfried. The investor will receive 51,899...